Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1995 Jun;221(6):734–743. doi: 10.1097/00000658-199506000-00012

Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma.

K M Olthoff 1, M H Rosove 1, C R Shackleton 1, D K Imagawa 1, D G Farmer 1, P Northcross 1, A L Pakrasi 1, P Martin 1, L I Goldstein 1, A Shaked 1, et al.
PMCID: PMC1234704  PMID: 7794077

Abstract

OBJECTIVE: The aim of this study was to evaluate the effect of postoperative adjuvant chemotherapy on the recurrence rate and survival of patients after orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). SUMMARY BACKGROUND DATA: Historically, liver transplantation for HCC has yielded poor long-term survival. Multimodality therapy has been initiated in an effort to improve survival statistics. METHODS: Twenty-five patients were placed on 6 months of intravenous fluorouracil, doxorubicin, and cisplatin after OLT. Risk factors, recurrence rates, and survival rates were analyzed and compared with historic controls. RESULTS: Overall long-term survival in the protocol patients was 46% at 3 years, improved over our historic controls of 5.8% at 3 years (p = 0.0001). Overall recurrence rate was 20% (n = 4). Possible risk factors, such as tumor size, vascular invasion, multifocality, capsular invasion, and tumor differentiation, were not found to be significantly predictive of survival. Three patients with long-term, disease-free survival had tumors > 5 cm. Side effects from chemotherapy were common, but rarely severe. CONCLUSIONS: This study suggests that adjuvant chemotherapy after transplantation for HCC can provide long-term cure and may improve survival, even in patients with stage III and IV disease.

Full text

PDF
734

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett N. L., Lum B. L., Fisher G. A., Brophy N. A., Ehsan M. N., Halsey J., Sikic B. I. Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance. J Clin Oncol. 1994 Apr;12(4):835–842. doi: 10.1200/JCO.1994.12.4.835. [DOI] [PubMed] [Google Scholar]
  2. Bismuth H., Chiche L., Adam R., Castaing D., Diamond T., Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993 Aug;218(2):145–151. doi: 10.1097/00000658-199308000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bismuth H., Morino M., Sherlock D., Castaing D., Miglietta C., Cauquil P., Roche A. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg. 1992 Apr;163(4):387–394. doi: 10.1016/0002-9610(92)90039-t. [DOI] [PubMed] [Google Scholar]
  4. Carr B. I., Selby R., Madariaga J., Iwatsuki S., Starzl T. E. Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma. Transplant Proc. 1993 Feb;25(1 Pt 2):1128–1129. [PMC free article] [PubMed] [Google Scholar]
  5. Chen M. F., Hwang T. L., Jeng L. B., Jan Y. Y., Wang C. S., Chou F. F. Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg. 1989 Sep;124(9):1025–1028. doi: 10.1001/archsurg.1989.01410090031006. [DOI] [PubMed] [Google Scholar]
  6. Cherqui D., Piedbois P., Pierga J. Y., Duvoux C., Vavasseur D., Tran Van-Nhieu J., LeBourgeois J. P., Julien M., Fagniez P. L., Dhumeaux D. Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study. Cancer. 1994 Jun 1;73(11):2721–2726. doi: 10.1002/1097-0142(19940601)73:11<2721::aid-cncr2820731112>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  7. Colombo M. Hepatocellular carcinoma. J Hepatol. 1992 May;15(1-2):225–236. doi: 10.1016/0168-8278(92)90041-m. [DOI] [PubMed] [Google Scholar]
  8. Farmer D. G., Rosove M. H., Shaked A., Busuttil R. W. Current treatment modalities for hepatocellular carcinoma. Ann Surg. 1994 Mar;219(3):236–247. doi: 10.1097/00000658-199403000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Haug C. E., Jenkins R. L., Rohrer R. J., Auchincloss H., Delmonico F. L., Freeman R. B., Lewis W. D., Cosimi A. B. Liver transplantation for primary hepatic cancer. Transplantation. 1992 Feb;53(2):376–382. doi: 10.1097/00007890-199202010-00021. [DOI] [PubMed] [Google Scholar]
  10. Iwatsuki S., Starzl T. E., Sheahan D. G., Yokoyama I., Demetris A. J., Todo S., Tzakis A. G., Van Thiel D. H., Carr B., Selby R. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg. 1991 Sep;214(3):221–229. doi: 10.1097/00000658-199109000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jurim O., Martin P., Shaked A., Goldstein L., Millis J. M., Calquhoun S. D., Gitnick G., Tong M. J., Busuttil R. W. Liver transplantation for chronic hepatitis B in Asians. Transplantation. 1994 May 15;57(9):1393–1395. doi: 10.1097/00007890-199405150-00019. [DOI] [PubMed] [Google Scholar]
  12. Kinami Y., Takashima S., Miyazaki I. Hepatic resection for hepatocellular carcinoma associated with liver cirrhosis. World J Surg. 1986 Apr;10(2):294–301. doi: 10.1007/BF01658148. [DOI] [PubMed] [Google Scholar]
  13. Nerenstone S. R., Ihde D. C., Friedman M. A. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev. 1988 Mar;15(1):1–31. doi: 10.1016/0305-7372(88)90007-2. [DOI] [PubMed] [Google Scholar]
  14. Olthoff K. M., Millis J. M., Rosove M. H., Goldstein L. I., Ramming K. P., Busuttil R. W. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg. 1990 Oct;125(10):1261–1268. doi: 10.1001/archsurg.1990.01410220045007. [DOI] [PubMed] [Google Scholar]
  15. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery. 1991 Oct;110(4):726–735. [PubMed] [Google Scholar]
  16. Pichlmayr R., Weimann A., Ringe B. Indications for liver transplantation in hepatobiliary malignancy. Hepatology. 1994 Jul;20(1 Pt 2):33S–40S. doi: 10.1016/0270-9139(94)90271-2. [DOI] [PubMed] [Google Scholar]
  17. Ringe B., Pichlmayr R., Wittekind C., Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg. 1991 Mar-Apr;15(2):270–285. doi: 10.1007/BF01659064. [DOI] [PubMed] [Google Scholar]
  18. Schwartz M. E. Primary hepatocellular carcinoma: transplant versus resection. Semin Liver Dis. 1994 May;14(2):135–139. doi: 10.1055/s-2007-1007306. [DOI] [PubMed] [Google Scholar]
  19. Sikic B. I. Modulation of multidrug resistance: at the threshold. J Clin Oncol. 1993 Sep;11(9):1629–1635. doi: 10.1200/JCO.1993.11.9.1629. [DOI] [PubMed] [Google Scholar]
  20. Stone M. J., Klintmalm G. B., Polter D., Husberg B. S., Mennel R. G., Ramsay M. A., Flemens E. R., Goldstein R. M. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology. 1993 Jan;104(1):196–202. doi: 10.1016/0016-5085(93)90852-4. [DOI] [PubMed] [Google Scholar]
  21. Yokoyama I., Carr B., Saitsu H., Iwatsuki S., Starzl T. E. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer. 1991 Nov 15;68(10):2095–2100. doi: 10.1002/1097-0142(19911115)68:10<2095::aid-cncr2820681002>3.0.co;2-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES